Arctic Aurora LifeScience H |
Performance History | 30/04/2025 |
Growth of 1,000 (EUR) |
![]() | Fund | 10.0 | -7.6 | 1.5 | -3.0 | -6.2 |
![]() | +/-Cat | - | - | - | - | - |
![]() | +/-Idx | - | - | - | - | - |
Category: Other Equity | ||||||
Benchmarks: - |
Key Stats | ||
NAV 08/05/2025 | NOK 1531.69 | |
Day Change | -1.02% | |
Morningstar Category™ | Other Equity | |
ISIN | IE00BDHFW354 | |
Fund Size (Mil) 31/03/2025 | NOK 1149.97 | |
Share Class Size (Mil) 30/04/2025 | NOK 125.99 | |
Max Initial Charge | - | |
Ongoing Charge 23/12/2024 | 1.13% |
Investment Objective: Arctic Aurora LifeScience H |
The investment objective is to achieve long-term capital appreciation through global equity investments within the pharmaceuticals, biotechnology and life science sectors. The team has more than 50 years of experience from the industry, and will utilize their know-how to pick the early winners in a fast developing life science and biotech space. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Ulrica Bjerke 27/05/2016 | ||
Daniel Bolanowski 01/06/2021 | ||
Inception Date 30/06/2016 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Pharma Bio&Life NR NOK | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Arctic Aurora LifeScience H | 30/04/2025 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 9.10 |
![]() | ![]() | 5.51 |
![]() | ![]() | 3.66 |
![]() | ![]() | 3.49 |
![]() | ![]() | 3.22 |
![]() | ||
![]() ![]() ![]() | ||
Arctic Aurora LifeScience H |